Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial. (2016)

First Author: Todd JA

Attributed to: Adaptive Clinical Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1002139

PubMed Identifier: 27727279

Publication URI: http://europepmc.org/abstract/MED/27727279

Type: Journal Article/Review

Volume: 13

Parent Publication: PLoS medicine

Issue: 10

ISSN: 1549-1277